Skip to main content
Top
Published in: Clinical Rheumatology 3/2011

01-03-2011 | Brief Report

Extreme hypercomplementemia in the setting of mixed cryoglobulinemia

Authors: Bharath Manu Akkara Veetil, Thomas G. Osborn, Dean F. Mayer

Published in: Clinical Rheumatology | Issue 3/2011

Login to get access

Abstract

Elevated levels of complement components, C3 and C4, are often seen in inflammatory diseases. They are generally not thought to be responsible for organ injury but simply reflect stimulation of the immune system. Extremely high elevations of these components are rarely seen. Such values are usually reported in patients with hematopoietic malignancies. We report here a case of C3 elevation to 9.22 g/L (5 times the upper limit of normal) and C4 elevation to 2.48 g/L (6 times the upper limit of normal). To our knowledge, no prior elevations of this magnitude have been reported previously from our institution or in the published medical literature (+/− MEDLINE search, using keywords hypercomplementemia, C3, C4, and lymphoplasmacytic lymphoma). In this case, there appeared to be no adverse end-organ damage from the excessive complement components or their activation.
Literature
1.
go back to reference Buchner H (1889) Über die bakterientödtende Wirkung des zellenfreien Blutserums. In: Zbl. Bact. I Abt. Orig.. Bd. 5, 817, Bd. 6, S. 1 Buchner H (1889) Über die bakterientödtende Wirkung des zellenfreien Blutserums. In: Zbl. Bact. I Abt. Orig.. Bd. 5, 817, Bd. 6, S. 1
2.
go back to reference Wink F, Houtman PM, Jansen TL. Rituximab in cryoglobulinaemic vasculitis, evidence for its effectivity: a case report and review of literature. Clin Rheumatol (in press) Wink F, Houtman PM, Jansen TL. Rituximab in cryoglobulinaemic vasculitis, evidence for its effectivity: a case report and review of literature. Clin Rheumatol (in press)
3.
go back to reference Frank MM (1987) Complement in the pathophysiology of human disease. N Engl J Med 316(24):1525–1530PubMedCrossRef Frank MM (1987) Complement in the pathophysiology of human disease. N Engl J Med 316(24):1525–1530PubMedCrossRef
4.
go back to reference Dhainaut JF et al (2001) Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit Care Med 29(7 Suppl):S42–S47PubMedCrossRef Dhainaut JF et al (2001) Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit Care Med 29(7 Suppl):S42–S47PubMedCrossRef
5.
go back to reference Ritchie RF et al (2004) Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 18(1):1–8PubMedCrossRef Ritchie RF et al (2004) Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 18(1):1–8PubMedCrossRef
6.
go back to reference Lospalluto J et al (1962) Cryoglobulinemia based on interaction between a gamma macroglobulin and 7S gamma globulin. Am J Med 32:142–147PubMedCrossRef Lospalluto J et al (1962) Cryoglobulinemia based on interaction between a gamma macroglobulin and 7S gamma globulin. Am J Med 32:142–147PubMedCrossRef
7.
go back to reference Riethmuller G et al (1966) Serum complement levels in patients with mixed (IgM–IgG) cryoglobulinaemia. Clin Exp Immunol 1(3):337–339PubMed Riethmuller G et al (1966) Serum complement levels in patients with mixed (IgM–IgG) cryoglobulinaemia. Clin Exp Immunol 1(3):337–339PubMed
8.
go back to reference Corvetta A et al (1983) Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia. Diagn Immunol 1(4):315–323PubMed Corvetta A et al (1983) Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia. Diagn Immunol 1(4):315–323PubMed
9.
go back to reference Tarantino A et al (1978) Serum complement pattern in essential mixed cryoglobulinaemia. Clin Exp Immunol 32(1):77–85PubMed Tarantino A et al (1978) Serum complement pattern in essential mixed cryoglobulinaemia. Clin Exp Immunol 32(1):77–85PubMed
10.
go back to reference Corvetta A et al (1983) Immune complexes and complement profile in essential mixed cryoglobulinemia before and after plasma exchange. Int J Artif Organs 6(Suppl 1):65–68PubMed Corvetta A et al (1983) Immune complexes and complement profile in essential mixed cryoglobulinemia before and after plasma exchange. Int J Artif Organs 6(Suppl 1):65–68PubMed
11.
go back to reference Montagnino G et al (1980) The complement system in essential mixed cryoglobulinemia. Ric Clin Lab 10(1):75–80PubMedCrossRef Montagnino G et al (1980) The complement system in essential mixed cryoglobulinemia. Ric Clin Lab 10(1):75–80PubMedCrossRef
12.
go back to reference Lai AFRF, van Furth R (1975) In vitro synthesis of some complement components (C1q, C3 and C4) by lymphoid tissues and circulating leucocytes in man. Immunology 28(2):359–368 Lai AFRF, van Furth R (1975) In vitro synthesis of some complement components (C1q, C3 and C4) by lymphoid tissues and circulating leucocytes in man. Immunology 28(2):359–368
13.
go back to reference Whaley K et al (1992) Synthesis of complement components by synovial membrane. Immunopharmacology 24(2):83–89PubMedCrossRef Whaley K et al (1992) Synthesis of complement components by synovial membrane. Immunopharmacology 24(2):83–89PubMedCrossRef
14.
go back to reference Lai AFRF, McClelland DB, van Furth R (1976) In vitro synthesis of immunoglobulins, secretory component, complement and lysozyme by human gastrointestinal tissues. I. Normal tissues. Clin Exp Immunol 23(1):9–19 Lai AFRF, McClelland DB, van Furth R (1976) In vitro synthesis of immunoglobulins, secretory component, complement and lysozyme by human gastrointestinal tissues. I. Normal tissues. Clin Exp Immunol 23(1):9–19
15.
go back to reference Lai a Fat RF, Suurmond D, van Furth R (1973) In vitro synthesis of immunoglobulins, secretory component and complement in normal and pathological skin and the adjacent mucous membranes. Clin Exp Immunol 14(3):377–395PubMed Lai a Fat RF, Suurmond D, van Furth R (1973) In vitro synthesis of immunoglobulins, secretory component and complement in normal and pathological skin and the adjacent mucous membranes. Clin Exp Immunol 14(3):377–395PubMed
16.
go back to reference Feucht HE et al (1989) Biosynthesis of complement C4 messenger RNA in normal human kidney. Nephron 53(4):338–342PubMedCrossRef Feucht HE et al (1989) Biosynthesis of complement C4 messenger RNA in normal human kidney. Nephron 53(4):338–342PubMedCrossRef
17.
go back to reference Walker DG, McGeer PL (1992) Complement gene expression in human brain: comparison between normal and Alzheimer disease cases. Brain Res Mol Brain Res 14(1–2):109–116PubMedCrossRef Walker DG, McGeer PL (1992) Complement gene expression in human brain: comparison between normal and Alzheimer disease cases. Brain Res Mol Brain Res 14(1–2):109–116PubMedCrossRef
18.
go back to reference La Civita L et al (1995) Mixed cryoglobulinemia as a possible preneoplastic disorder. Arthritis Rheum 38(12):1859–1860PubMedCrossRef La Civita L et al (1995) Mixed cryoglobulinemia as a possible preneoplastic disorder. Arthritis Rheum 38(12):1859–1860PubMedCrossRef
19.
go back to reference Vitali C et al (1994) Hypercomplementaemia as a marker of the evolution from benign to malignant B cell proliferation in patients with type II mixed cryoglobulinaemia. Br J Rheumatol 33(8):791–792PubMedCrossRef Vitali C et al (1994) Hypercomplementaemia as a marker of the evolution from benign to malignant B cell proliferation in patients with type II mixed cryoglobulinaemia. Br J Rheumatol 33(8):791–792PubMedCrossRef
Metadata
Title
Extreme hypercomplementemia in the setting of mixed cryoglobulinemia
Authors
Bharath Manu Akkara Veetil
Thomas G. Osborn
Dean F. Mayer
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 3/2011
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-010-1652-7

Other articles of this Issue 3/2011

Clinical Rheumatology 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.